Topic: Anyone following the ebola outbreak? - page 26. (Read 39823 times)

Ebola may have gone airborne already. Also there is another early stage plague potentially developing. Details at the following thread.

https://bitcointalksearch.org/topic/m.8305515

"The World Health Organization gathered a group of ethicists to decide whether untested medications and vaccines should be used in the current Ebola outbreak. As the death toll from the epidemic soared over 1,000, the WHO panel unanimously concluded it is ethical to offer medications to fight the Ebola virus, even if their effectiveness or adverse effects are unknown."

http://edition.cnn.com/2014/08/12/health/ebola-outbreak/

This is very serious. This is a disease that does not have a proven cure. Yes the one doctor was able to make a recovery when given the experimental drug, but it is far from certain that it would work on the masses. This is something that can kill you in a matter of days. If you get it you are almost certain to die from it.

Ebola outbreak? Seriously? That what you are afraid of?

President of Liberia Ellen Johnson Sirlea apologized publicly for many deaths of medical staff who died while taking care of virus victims. She also promised help in the amount of eighteen million dollars. Since February Ebola killed 963 people.

" On Monday, August 11, WHO is convening a panel discussion of medical ethicists, scientific experts and lay people from affected countries to assess the role of experimental therapies in the Ebola outbreak response.
Issues to be considered include:

• Whether it is ethical to use unregistered interventions with unknown adverse effects for possible treatment or prophylaxis. If it is, what criteria and conditions need to be satisfied before they can be used?

• If it is ethical to use these unregistered interventions in the circumstances mentioned above, then what criteria should guide the choice of the intervention and who should receive priority for treatment or prevention?"

http://www.who.int/csr/disease/ebola/ethics-panel-discussion/en/

Whoops!

What share prices...where talking about a government funded research center.
Vector is the State Research Center of Virology and Biotechnology and is owned by the government.

I think it's more likely they've had a vaccine (or a few candidates), but it wasn't (and possibly isn't) quite ready. If you haven't worked everything out for a drug, try to take it to market, and then the regulators smack it down, that's no good for share prices. They may be banking on the scare allowing faster and "lighter" approval by regulators for humanitarian, economic, and prestige reasons on the part of the state. It's a conflict of interest which risks creating a vaccine-derived ebolavirus pandemic (similar to VDPV, though rate of occurrence there is extremely, "safely" low) if the regulators aren't incorruptible hardasses.

One single person (a flight passenger from Liberia) has infected 9 other people in Nigeria. Some of them were sitting in the aircraft next to him. That shows how contagious this virus is. And even worse, they haven't yet quarantined every person who had contact with the Liberian passenger. 

A suspected case of Ebola has made it to Toronto

http://www.nytimes.com/reuters/2014/08/08/world/africa/08reuters-health-ebola-canada.html?ref=world&_r=1&referrer=


Hmmm... Unless this person had direct contact with the medical personnel or was on a flight with the man that took the virus to Nigeria, then I wouldn't be too concerned about this one. There have only been 9 cases of Ebola in Nigeria so far and all of them stem from the same patient in Lagos.

The death toll is fast approaching 1,000 mark. I just hope that the disease stays out of Nigeria. If Nigeria gets hit, then millions of lives will be lost. Nigeria is very densely populated, unlike countries such as Guinea and Liberia.

BTW.. has anyone have any information on the Saudi case?

Maybe this project was frozen and forgotten for a while... It happens sometimes due to financial purposes, the US have frozen ebola vaccine projects since 2012, for example.

http://www.bbc.co.uk/news/science-environment-19112510

Actually you can blame anybody.

They have worked on a vaccine for humans , that was the whole point of the research.
They have used it only on rats till now but, still ,....too much of a coincidence for a work that started 10 years ago to be released in the news just now.

If it where for the us everybody would have seen them as the ones spreading the virus and then miraculously finding a cure...
Of course we can't blame this scenario on the Russians... can't we?

Maybe. They haven't worked on the vaccine for humans at that time, their ebola related experiments were performed on rats and rabbits only.

You know , having worked for 10 years at least on this vaccine and finding it right now , it seems a bit weird at least , isn't it?

By the way, two members of Vector staff have died from ebola desease after getting accidentally infected. It happened ~10 years ago.

Well, Vector inherited some goodies from Biopreparat .

http://en.ria.ru/russia/20140805/191739156/Russian-Ebola-Vaccine-in-Preclinical-Trials.html

Well I guess when the mortality rate is this high it really could just use a field trial
Yes I am saying human experimentation of new untested drugs on individuals might be the solution for once.

Anyways interesting enough there are two potential candidates for the job not just one
But it does raise the question who gets it first couple news articles

__
Anti-Ebola drugs not ready for use in African outbreak
Drug tried on two infected Americans has not been tested for safety and efficacy and ‘there are virtually no doses available,’ CDC says.
http://www.thestar.com/news/world/2014/08/07/antiebola_drugs_not_ready_for_use_in_african_outbreak.html

MONROVIA, LIBERIA—Africans seeking a drug to help contain the Ebola virus will have to wait months before a potentially life-saving experimental treatment used on two infected Americans is produced even in small amounts, officials said.

There are no guarantees that the medication known as ZMapp, from San Diego-based Mapp Biopharmaceutical Inc., would help curb the spread of the dreaded disease, which starts with a fever and body aches and sometimes progresses to serious bleeding. Supplies of the drug are limited. It has never been tested for safety or effectiveness in humans.

The health minister of Nigeria, one of the four countries where Ebola has broken out, told a news conference in his country that he had asked the U.S. Centers for Disease Control and Prevention about access to the drug. A CDC spokesman said Wednesday “there are virtually no doses available.”

Testing an unproven drug on a large population carries risks. Earlier this week, the CDC director emphasized that it’s impossible to know whether ZMapp helped the sick American aid workers.

“Until we do a study, we don’t know if it helps, if it hurts or if it doesn’t make any difference,” Tom Frieden told a health symposium in Kentucky.
___

In Ebola Outbreak, Who Should Get Experimental Drug?

Some have said it is wrong that with hundreds of Africans dying from the outbreak of Ebola, extremely scarce supplies of an experimental drug went to two white American aid workers.

But what if the first doses of the drug — which had never been used in people and had not even finished the typical animal safety testing — had been given to African patients instead?

“It would have been the front-page screaming headline: Africans used as guinea pigs for American drug company’s medicine,” said Dr. Salim S. Abdool Karim, director of Caprisa, an AIDS research center in South Africa.

A history of controversy about drug testing in Africa is just one of the complexities facing public health authorities as they wrestle with whether and how to bring that drug and possibly other experimental ones to the countries afflicted with Ebola. Who should get such a scarce supply of medicine? Health workers? Children? The newly infected who are not yet as sick?

Other experimental medicines might be available, but also probably in small amounts, like one from Tekmira Pharmaceuticals that has so far been tested only in healthy volunteers. Tekmira said Thursday that the Food and Drug Administration had determined the drug was safe enough to be tried in infected patients.
___

http://www.businessinsider.com/ebola-drug-company-tekmira-2014-8

Might be worth a share purchase
DRUG FIRM TEKMIRA SAYS FDA MAY ALLOW USE OF EBOLA DRUG ON PATIENTS

Individuals infected with the Ebola virus might be able to get access to TKM-Ebola, a drug that's been held up in Phase I clinical trials by the FDA.

Shares of Tekmira Pharmaceuticals, the company behind the drug, were halted at around 4:00 p.m. ET.

Here's what management is said in its 4:45 p.m. ET press release: "[Tekmira] today announced that the U.S. Food & Drug Administration (FDA) has verbally confirmed they have modified the full clinical hold placed on the TKM-Ebola Investigational New Drug Application (IND) to a partial clinical hold. This action enables the potential use of TKM-Ebola in individuals infected with Ebola virus."